Workflow
GSK Stock Drops as UK Firm Posts Underwhelming Results
GSKGSK(GSK) Investopedia·2024-10-30 20:40

KEY TAKEAWAYS GSK's shares are falling 4% in premarket trading Wednesday after the British pharma giant posted lowerthan-estimated quarterly sales and lowered its projection for vaccine sales. The company reported third-quarter sales of 8.01 billion pounds ($9.59 billion), down 2% year-over-year on lower vaccine sales and below consensus estimates of analysts polled by Visible Alpha of 8.09 billion pounds. The U.K. firm, whose vaccines include Arexvy and Shingrix, now expects 2024 vaccine sales to decrease ...